Preserving renal function in adults with hypertension and diabetes: a consensus approach

GL Bakris, M Williams, L Dworkin, WJ Elliott… - American journal of …, 2000 - Elsevier
Over 11 million Americans have both diabetes and hypertension—comorbid diseases that
strongly predispose people to both renal as well as cardiovascular (CV) injury. Hypertension …

Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis

WJ Elliott, PM Meyer - The Lancet, 2007 - thelancet.com
Background The effect of different classes of antihypertensive drugs on incident diabetes
mellitus is controversial because traditional meta-analyses are hindered by heterogeneity …

Principal results of the controlled onset verapamil investigation of cardiovascular end points (CONVINCE) trial

HR Black, WJ Elliott, G Grandits, P Grambsch… - Jama, 2003 - jamanetwork.com
ContextHypertensive patients are often given a calcium antagonist to reduce cardiovascular
disease risk, but the benefit compared with other drug classes is controversial.ObjectiveTo …

Circadian variation in the timing of stroke onset: a meta-analysis

WJ Elliott - Stroke, 1998 - Am Heart Assoc
Background and Purpose—Acute myocardial infarction and sudden death display a circadian
rhythm, with a higher risk between 6 am and noon. Some reports suggest that stroke does …

Beyond medications and diet: alternative approaches to lowering blood pressure: a scientific statement from the American Heart Association

…, G Ogedegbe, JD Bisognano, WJ Elliott… - …, 2013 - Am Heart Assoc
Many antihypertensive medications and lifestyle changes are proven to reduce blood
pressure. Over the past few decades, numerous additional modalities have been evaluated in …

Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and …

…, RS Blumenthal, CP Cannon, JA De Lemos, WJ Elliott… - Circulation, 2015 - Am Heart Assoc
(AHA) scientific statement “Treatment of Hypertension in the Prevention and Management of
Ischemic Heart Disease: A Scientific Statement From the American Heart Association …

Initial assessment, surveillance, and management of blood pressure in patients receiving vascular endothelial growth factor signaling pathway inhibitors

…, HX Chen, JB Durand, WJ Elliott… - Journal of the …, 2010 - academic.oup.com
Hypertension is a mechanism-based toxic effect of drugs that inhibit the vascular endothelial
growth factor signaling pathway (VSP). Substantial evidence exists for managing …

[HTML][HTML] Calcium channel blockers

WJ Elliott, CVS Ram - The Journal of Clinical Hypertension, 2011 - ncbi.nlm.nih.gov
Key Points and Practical Recommendations• Calcium channel blockers, which dilate
arteries by reducing calcium flux into cells, effectively lower blood pressure, especially in …

Resistant hypertension revisited: a comparison of two university-based cohorts

JP Garg, WJ Elliott, A Folker, M Izhar… - American journal of …, 2005 - academic.oup.com
Background: More than a decade ago, we found that a suboptimal medication regimen was
the leading cause of resistant hypertension (RH) among patients referred to a tertiary care …

Baseline characteristics and early blood pressure control in the CONVINCE trial

HR Black, WJ Elliott, JD Neaton, G Grandits… - …, 2001 - Am Heart Assoc
Blood pressure (BP) control rates around the world are suboptimal. Part 2 of the National
Health and Nutrition Educational Survey (NHANES) III indicates that only 27.4% of …